Finance

Beta
Lists
PNGAF:OTCMKTS
Precision Peptide Company Inc
$0.36
-0.64%
(-0.0023) 1D
Jun 3, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PNGAF...
Open
$0.41
High
$0.41
Low
$0.35
Mkt. cap
23.37M
Avg. vol.
44.36K
Volume
56.21K
52-wk high
$0.50
52-wk low
$0.01
Beta
2.17
Shares outstanding
43.57M
No. of employees
2
Open
$0.41
High
$0.41
Low
$0.35
Mkt. cap
23.37M
Avg. vol.
44.36K
Volume
56.21K
52-wk high
$0.50
52-wk low
$0.01
Beta
2.17
Shares outstanding
43.57M
No. of employees
2
News stories
From sources across the web
About Precision Peptide Company Inc
CEO-
Employees2
Founded2021
HeadquartersSurrey, British Columbia, Canada
SectorFood
Websitepangea-wellness.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
5.92K
43.80K
42.99K
Cost of goods sold
-
1.93K
25.84K
7.50K
Cost of revenue
-
1.93K
25.84K
7.50K
Research and development expenses
-
-
26.58K
37.16K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
266.62K
623.49K
1.07M
660.57K
Operating expense
266.62K
668.38K
1.14M
1.47M
Total operating expenses
266.62K
670.31K
1.17M
1.48M
Operating income
-266.62K
-664.40K
-1.12M
-1.44M
Other non operating income
-
1.98K
-
-
EBT including unusual items
-315.73K
-661.83K
-3.40M
-1.40M
EBT excluding unusual items
-315.73K
-661.83K
-1.15M
-1.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-315.73K
-661.83K
-3.40M
-1.40M
Net profit margin
-
-11,187.07%
-7,761.55%
-3,259.20%
Earnings per share
-
-
-
-
Interest and investment income
-
592.00
8.18K
1.03K
Interest expense
-
-
-
-
Net interest expenses
-
592.00
8.18K
1.03K
Depreciation and amortization charges
-
44.89K
46.23K
-
EBITDA
-265.74K
-649.43K
-1.08M
-1.41M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer